AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 19544555
Drug: L-arginine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine supplementation
Trial: 29545253
Drug: Intra-arterial infusion
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial infusion of bone marrow-derived mononuclear cells
Trial: 9347199
Drug: Ethanol infusion
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol infusion
Trial: 2666484
Drug: Transdermal scopolamine
RxNorm normalized name: Transderm Scop
DrugBank: Scopolamine (DB00747)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal scopolamine (TS) patch
Trial: 27707817
Drug: evolocumab 140
RxNorm normalized name: evolocumab 140 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: evolocumab 140 mg
Trial: 27707817
Drug: evolocumab 420
RxNorm normalized name: evolocumab 420 in 3.5 ML Cartridge
FDA approved: no
EMA approved: no
PMDA approved: no
Description: evolocumab 420 mg
Trial: 22751965
Drug: Individual withdrawal
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individual withdrawal with restricted symptomatic medication and prophylactics from Day 1 (Group A)
Trial: 22751965
Drug: Two-month drug-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-month drug-free period with multidisciplinary education in groups (Group B)
Trial: 11273876
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (15 mg intravenously three times weekly)
Trial: 11273876
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid (16.1 mg intravenously three times weekly)
Trial: 2050174
Drug: Sublingual captopril
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual captopril (25 mg)
Trial: 2012448
Drug: Sublingual nifedipine
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual nifedipine (10 mg)
Trial: 8247194
Drug: Sublingual prazosin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual prazosin (2 mg)
Trial: 3930305
Drug: 6 capsules
RxNorm normalized name: TOBI Podhaler Weekly Kit, including 56 capsules (7 Blister Cards of 8 Capsules)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 capsules of carotenoids (10 mg beta‐carotene + 15 mg canthaxanthin per capsule)
Trial: 3930305
Drug: 4 capsules
RxNorm normalized name: Jynarque 60 MG / 30 MG Carton Pack, 4 Blister Cards, 14 Capsules Each
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 capsules of carotenoids (10 mg beta‐carotene + 15 mg canthaxanthin per capsule)
Trial: 3930305
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (4 and 6 capsules)
Trial: 27776679
Drug: Quitline services
RxNorm normalized name: quinoline yellow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quitline services (QL) including a motivational interview, 6 weeks of nicotine patches and gum, a referral to the QL, a booster call, and a quitline brochure.
Trial: 12692805
Drug: Parenteral Nutrition
RxNorm normalized name: parenteral nutrition solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral Nutrition (PN)
Trial: 8576291
Drug: Fluid therapy
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid therapy
Trial: 22551742
Drug: Treatment by
RxNorm normalized name: By Ache
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment by a homeopath
Trial: 15703163
Drug: Brachial intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brachial intra-arterial propranolol infusion in Gly(16)/Glu(27)
Trial: 15703163
Drug: Brachial intra-arterial
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Brachial intra-arterial propranolol infusion in Arg(16)/Gln(27)
Trial: 9633736
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose intravenous methylprednisolone (IVMP)
Trial: 9633736
Drug: Lower dose
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower dose intravenous methylprednisolone (IVMP)
Trial: 8164314
Drug: Sebacate (6.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sebacate (6.6 g/h)
Trial: 3356852
Drug: High levels
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High levels of maternal IgG, IgA, or IgM antibodies to food at delivery
Trial: 31119578
Drug: WBC count
RxNorm normalized name: oteseconazole
DrugBank: Oteseconazole (DB13055)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: WBC count modifications with elevated CRP (> 40 mg/L) or fever (> 38.5 °C) in infected patients
Trial: 23568049
Drug: Low-volume polyethylene
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-volume polyethylene glycol plus bisacodyl (BPEG) 30 mL kg⁻¹ day⁻¹ plus oral bisacodyl 10 to 15 mg/day
Trial: 23568049
Drug: Sennosides 2
RxNorm normalized name: sennosides 25 mg ORAL PILL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sennosides 2 mg kg⁻¹ day⁻¹
Trial: 11587253
Drug: Calcium-fortified milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium-fortified milk supplement (3 L weekly in the first year)
Trial: 11587253
Drug: Calcium-fortified milk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium-fortified milk supplement
Trial: 8162479
Drug: Active low
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active low level laser therapy (LLLT)
Trial: 3144923
Drug: 2 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg.kg‐1 ketoprofen intravenously over 20 min
Trial: 27916783
Drug: Insulin treatment
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin treatment (control group)
Trial: 25448243
Drug: Epidural steroid
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural steroid injections (SESIs) - 80mg of triamcinolone in normal saline
Trial: 19500693
Drug: Virologic response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Virologic response (levels of hepatitis B virus DNA below 10,000 copies/mL)
Trial: 16885758
Drug: Rectal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Rectal administration of acetaminophen with codeine
Trial: 16885758
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of acetaminophen with codeine
Trial: 3139138
Drug: Intravenous salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous salbutamol (12 micrograms/min continuous infusion for 4 hours)
Trial: 3139138
Drug: Nebulised salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulised salbutamol (5 mg nebulised on admission, plus two more 5 mg doses at 30 minutes and 2 hours)
Trial: 16959472
Drug: ondansetron (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ondansetron (8 mg/day) combined with haloperidol (4-30 mg/day)
Trial: 16959472
Drug: placebo combined
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo combined with haloperidol (4-30 mg/day)
Trial: 9348566
Drug: MMC/UFT (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMC/UFT (20 mg of MMC sprinkled on the operating field, 6 mg/m2 of MMC intravenously on day 7 and monthly for 6 months, 400 mg/day of UFT orally for 1 year)
Trial: 1316914
Drug: Percoll preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Percoll preparation
Trial: 8907672
Drug: Swim-up preparation
RxNorm normalized name: arched swimming crab, cooked preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Swim-up preparation
Trial: 23028596
Drug: Pre-meal protein
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre-meal protein drinks (PMPD) containing whey protein isolates (9 g protein)
Trial: 19776051
Drug: Niacinamide (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Niacinamide (250 mg twice daily, titrated to 750 mg twice daily)
Trial: 2071085
Drug: Nisoldipine 10
RxNorm normalized name: nisoldipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 10 mg/day
Trial: 2071085
Drug: Diltiazem 3
RxNorm normalized name: diltiazem 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 3 x 60 mg/day
Trial: 6404238
Drug: Cost analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost analysis with prophylactic antibiotics
Trial: 25025992
Drug: Calcium channel
RxNorm normalized name: Calcium channel blocker
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium channel blockers (CCBs) alone
Trial: 22145610
Drug: ABT-594 150
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-594 150 μg
Trial: 22145610
Drug: ABT-594 225
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-594 225 μg
Trial: 22145610
Drug: ABT-594 300
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-594 300 μg
Trial: 2735330
Drug: sucralfate 2
RxNorm normalized name: sucralfate 200 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sucralfate 2 g twice daily for six weeks
Trial: 2735330
Drug: ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ranitidine 300 mg at bedtime
Trial: 2735330
Drug: pentagastrin 0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pentagastrin 0.1 and 6.0 micrograms/kg/hour or histamine acid phosphate 4.0 and 40 micrograms/kg/hour (secretory stimulants)
Trial: 30479044
Drug: Silymarin 1%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin 1% gel
Trial: 28436572
Drug: 1200 mg
RxNorm normalized name: aspirin 1200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1200 mg delayed-release cysteamine bitartrate
Trial: 25900350
Drug: Levodopa (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levodopa (100 mg administered at each session for five sessions over 1 week)
Trial: 25900350
Drug: Placebo (administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (administered at each session for five sessions over 1 week)
Trial: 23568575
Drug: Donepezil (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (10 mg)
Trial: 18248656
Drug: Lubiprostone (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lubiprostone (all doses)
Trial: 25664604
Drug: Oral octreotide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral octreotide capsules (OOCs)
Trial: 26551445
Drug: Lactobacillus reuteri
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus reuteri DSM 17938 (1 × 10 colony forming units daily)
Trial: 22559011
Drug: Probiotic comprising
RxNorm normalized name: Rezyst Probiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotic comprising two strains of lactobacilli and two strains of bifidobacteria, one capsule daily for 21 days
Trial: 22559011
Drug: Matching placebo,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching placebo, one capsule daily for 21 days
Trial: 20484917
Drug: semi-standardised acupuncture
RxNorm normalized name: Semi-Daonil
DrugBank: Glyburide (DB01016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: semi-standardised acupuncture plus rescue medication (cetirizine)
Trial: 20484917
Drug: penetrating sham
FDA approved: no
EMA approved: no
PMDA approved: no
Description: penetrating sham acupuncture at non-acupuncture points plus rescue medication
Trial: 20484917
Drug: rescue medication
RxNorm normalized name: ALLERGENIC EXTRACT, MEADOW FESCUE POLLEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rescue medication alone for 8 weeks (standard treatment group)
Trial: 16048984
Drug: Nelfinavir and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nelfinavir and efavirenz (combination)
Trial: 7537287
Drug: risperidone 8
RxNorm normalized name: Risperidone
DrugBank: Risperidone (DB00734)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: risperidone 8 mg
Trial: 7537287
Drug: clozapine 400
RxNorm normalized name: clozapine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: clozapine 400 mg
Trial: 7537287
Drug: risperidone (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: risperidone (both doses)
Trial: 8445418
Drug: Carboplatin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carboplatin (400 mg/m2)
Trial: 2045855
Drug: Iproplatin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iproplatin (300 mg/m2)
Trial: 7019932
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg emepronium bromide 3-times daily
Trial: 21836528
Drug: TXA (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXA (10 mg/kg at induction followed by 1 mg/kg/h infusion)
Trial: 9299382
Drug: Standard Stroop
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard Stroop stimuli (e.g., the word 'RED' displayed in a green font)
Trial: 24837060
Drug: Hypnobehavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypnobehavioral therapy enhanced by energetic psychotherapy (HypEn)
Trial: 23957874
Drug: Peer‐ and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peer‐ and family‐based group therapies
Trial: 1356175
Drug: Monthly pulse
RxNorm normalized name: dulse extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monthly pulse cyclophosphamide for 6 months
Trial: 3893195
Drug: Clonidine (3‐600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine (3‐600 micrograms, six hourly)
Trial: 3893195
Drug: Chlormethiazole (500‐1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlormethiazole (500‐1000 mg, six hourly)
Trial: 31470175
Drug: Curcumin (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Curcumin (3 g/day)
Trial: 22313079
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g intravenous paracetamol intraoperatively
Trial: 22313079
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g oral paracetamol 30 to 60 minutes preoperatively
Trial: 30644983
Drug: Hematopoietic stem
RxNorm normalized name: Umbilical Cord Blood Hematopoietic Stem Cells
DrugBank: Umbilical Cord Blood Hematopoietic Stem Cells (DB15723)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hematopoietic stem cell transplantation (HSCT) with cyclophosphamide (200 mg/kg) and antithymocyte globulin (6 mg/kg)
Trial: 30644983
Drug: Disease-modifying therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Disease-modifying therapy (DMT)
Trial: 28901892
Drug: Anthocyanin (ACN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthocyanin (ACN) supplementation (320 mg/d)
Trial: 28901892
Drug: Placebo (PBO)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PBO) treatment
Trial: 2148223
Drug: Isradipine SRO
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isradipine SRO (5 mg) given at either 9 am or 9 pm
Trial: 22195356
Drug: Valsartan (angiotensin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valsartan (angiotensin II receptor blocker)
Trial: 23448396
Drug: DHEA (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA (all doses)
Trial: 20709233
Drug: Rimonabant 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rimonabant 20 mg
Trial: 15588275
Drug: Hormone levels
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone levels (FSH, LH, estradiol, progesterone) in patients with CFS
Trial: 15588275
Drug: Hormone levels
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone levels in patients with high depression scores
Trial: 31440031
Drug: Oral Yimaxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Yimaxin
Trial: 31440031
Drug: Oral Utrogestan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Utrogestan
Trial: 12664518
Drug: Tramadol 1
RxNorm normalized name: tramadol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol 1 mg/kg
Trial: 30283029
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg/kg
Trial: 26044602
Drug: Saline 2
RxNorm normalized name: SODIUM CHLORIDE BRONCHO-SALINE 240ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline 2 mL (Control)
Trial: 24112401
Drug: Collagenase clostridium
RxNorm normalized name: Collagenase Clostridium Histolyticum
DrugBank: Collagenase clostridium histolyticum (DB00048)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagenase clostridium histolyticum (CCH) - investigational intralesional injection
Trial: 8237624
Drug: Bendrofluazide 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bendrofluazide 2.5 mg daily
Trial: 3614616
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mg orally prior to sleep)
Trial: 3614616
Drug: Hydrocortisone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (100 mg infusion throughout the night)
Trial: 27046309
Drug: Cariprazine 2-4.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 2-4.5 mg/d
Trial: 27046309
Drug: Cariprazine 1-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cariprazine 1-2 mg/d
Trial: 12105285
Drug: Bupropion SR
RxNorm normalized name: Bupropion Hydrochloride 100 MG Oral Tablet, Extended Release, 12 HR [BUPROPION SR]
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bupropion SR 400 mg/d
Trial: 31232139
Drug: High-dose atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose atorvastatin (40 mg/d) combined with aspirin (100 mg/d)
Trial: 31232139
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose atorvastatin (20 mg/d) combined with aspirin (100 mg/d)
Trial: 14574055
Drug: BNP-guided treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BNP-guided treatment
Trial: 15671129
Drug: Oral zuclopenthixol
RxNorm normalized name: zuclopenthixol
DrugBank: Zuclopenthixol (DB01624)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral zuclopenthixol
Trial: 11910616
Drug: Transdermal progesterone
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Transdermal progesterone cream (16, 32, or 64 mg daily for 14 days)
Trial: 11910616
Drug: Transdermal estrogen
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogen (continuous for 28-day cycle)
Trial: 8116856
Drug: Lysine acetylsalicylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lysine acetylsalicylate (162 mg)
Trial: 8116856
Drug: Furosemide (18
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (18 mg)
Trial: 8116856
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of lysine acetylsalicylate and furosemide
Trial: 30445008
Drug: Dexlansoprazole (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexlansoprazole (60 mg)
Trial: 31764785
Drug: Rivaroxaban (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban (10 mg/day, orally)
Trial: 31764785
Drug: LMWH (Enoxaparin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LMWH (Enoxaparin, 4000 anti-Xa IU/day, subcutaneous injection)
Trial: 31764785
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no anticoagulant)
Trial: 28499376
Drug: Mindfulness-based childbirth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-based childbirth preparation course (MIL)
Trial: 28499376
Drug: Standard childbirth
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard childbirth preparation course (Control)
Trial: 12911658
Drug: Ecabet sodium
RxNorm normalized name: ecabet sodium
DrugBank: Ecabet (DB05265)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ecabet sodium 1 g b.i.d and cimetidine 400 mg b.i.d.
Trial: 11164441
Drug: Therapeutic goal
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic goal of total cholesterol < 5.0 mmol/l
Trial: 11164441
Drug: Therapeutic goal
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic goal of total cholesterol < 4.5 mmol/l
Trial: 9280037
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran fibre supplement
Trial: 8243794
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day tenoxicam
Trial: 8243794
Drug: 100 mg/day
RxNorm normalized name: infigratinib phosphate 100 mg/day (100 mg x 1) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg/day diclofenac sodium